Webcast: UPC Fireside Chat

Dr. Matthias Zigann is a designated legally qualified judge at the Unified Patent Court (Local Division Munich) and Presiding Judge at the Munich Higher Regional Court. There he is heading the 38th Civil Senate since November 2022. From December 2012 to October 2022, he presided over the 7th (Patent) Division of the Munich Regional Court I. Prior to his appointment as presiding judge he was seconded to serve as a research associate with the Xth Civil (Patent) Senate of the German Federal Court of Justice in Karlsruhe for three years. Dr. Zigann is i.a. co-editor and co-author of the Beck Online Commentary UPC (to go online end of 2023).

Dr. Tobias Wuttke is a partner of Bardehle Pagenberg since 1st January 2023. Each year, he deals with over 30 in-court IP litigation cases and far more out-of-court disputes. He is recognised by JUVE, Legal 500, Chambers and IAM as a leading patent litigator in Germany.

Thorsten Bausch serves as Partner in HOFFMANN EITLE’s Chemistry and Biotech practice group, with a strong focus on EPO Opposition and Appeal Proceedings and on German revocation and infringement proceedings. Thorsten has practiced for almost 30 years in the chemical, pharmaceutical and biotechnology arts. Clients have called Thorsten "one of the best patent attorneys in Europe" and Peers have praised him as "the guiding light of patent enforcement in the pharmaceutical sector in Germany" (IP Stars Handbook 2017) and "definitely one of the go-to patent attorneys in Germany for SPCs" (iam Patent 1000). He is perennially recognized by Chambers, Managing Intellectual Property, Wirtschaftswoche, JuVe, among many others. Who’s Who Legal 2021 named Thorsten as "Thought Leader Global Elite" for Germany. Thorsten serves and represents clients through all strata, from startups to fortune 500 companies as well as some of the most prestigious universities and research institutions in the world. He has acquired particular expertise in the fields of pharmaceuticals, immunology and polymers. Many pharmaceutical patents of major commercial value have been entrusted to Thorsten and his team at HOFFMANN EITLE. Thorsten was also in involved in Decision G 1/99 before the EPO’s Enlarged Board of Appeal and contributed to Case G 1/21 as an amicus curiae. In 2021, Thorsten was invited to join the Standing Advisory Committee of the European Patent Office on Quality.